RSMD Enduring Aesthetics Program

Program Overview

This course provides the knowledge and procedural guidance needed for new and experienced injectors to gain foundational expertise in the use of botulinum toxin for facial aesthetic procedures. Through didactic lecture, reading assignments, and case demonstrations, clinicians will learn to learn to deconstruct facial anatomy into individual muscles and component treatment areas, conceptually reconstruct the face, viewing it as a whole, and gain skill in balancing adjacent muscles to integrate toxin for the best clinical results and a natural pattern of aging over time. Safety zones, correct doses, and injection techniques will be demonstrated and discussed.

Target Audience

The target audience includes clinicians who which to gain proficiency in botulinum toxin injections, including physician assistants, nurses, and physicians.

Release and Expiration Dates

Provided by UAMS after approval.

Measurable Learning Objectives

  1. Identify the individual muscles to be treated with botulinum toxin for best clinical results.

  2. Dose botulinum toxin correctly for a variety of facial areas.

  3. Inject botulinum toxin within safety zones of the face, and avoid injecting in areas that cause adverse events.

  4. Identify good candidates for injections and develop a treatment plan that results in success and patient satisfaction.

References

Ahsanuddin S, Roy S, Nasser W, Povolotskiy R, Paskhover B. Adverse events associated with Botox as reported in a Food and Drug Administration database. Aesthetic Plast Surg. 2021;45(3):1201-1209.

Alam M, Bolotin D, Carruthers J, et al. Consensus statement regarding storage and reuse of previously reconstituted neuromodulators. Dermatol Surg. 2015;41(3):321-326.

Cohn JE, Greco TM. Advanced techniques for the use of neurotoxins in non-surgical facial rejuvenation. Aesthetic plastic surgery. 2020 Oct;44(5):1788-99.

Jabbour S, Kechichian E, Awaida C, Nasr M. Updates in the treatment of the lower face and neck with botulinum toxin injections. Aesthetic Surg J. 2019 Mar 14;39(4):NP93-4.

Park MY, Ahn KY. Scientific review of the aesthetic uses of botulinum toxin type A. Arch Craniofac Surg. 2021;22(1):1-10. 

Sethi N, Singh S, DeBoulle K, Rahman E. A review of complications due to the use of botulinum toxin A for cosmetic indications. Aesthetic Plast Surg. 2021;45(3):1210-1220.

Small R. Small’s Practical Guide to Botulinum Toxin Procedures. Lippencott, Williams & Wilkins. Philadelphia, PA. 2024.

Dr. Rebecca Small in-office training with residents from Stanford O'Connor Hospital, UCSF - Natividad, Dominican Hospital, and Kaiser Santa Clara

Disclosures

The planners, faculty, and peer-reviewers of the CE activity have no relevant financial relationships with ineligible companies to disclose.

Planners

Jade Ryan, MA, Ed
Meghan Craddock, RN
Jaime Shaffer

Peer Reviewer

Stanislava Matejin, MD Family Medicine Resident at Dominican Hospital.

Speaker

Rebecca Small, MD

Speaker Bio

Rebecca Small, MD is a leading authority in combining non-surgical medical aesthetic therapies to slow the signs of aging. She is a graduate of Cambridge University, England, and Harvard Medical School. Dr. Small is a Clinical Professor at the University of California San Francisco (UCSF) School of Medicine where she trains Plastic Surgery and Family Medicine physicians on non-surgical medical aesthetics.

Dr. Small is also the best-selling author of the Practical Guide to medical aesthetics textbook series. The series, which covers botulinum toxins, dermal fillers, lasers, and medical skincare, has been translated into 8 languages and sold more than 50,000 copies worldwide. These textbooks consistently achieve “#1 Best Seller” in Amazon’s Plastic Surgery, Dermatology, and Laser Medicine categories; garnering more than 1,000 5-star reviews.

At RSMD Medical Aesthetics, Dr. Small serves as the hands-on Medical Director. 

Instructions to Obtain Credit

For each module:

  1. Launch the activity

  2. View each module online

  3. Read the assigned reading

  4. Complete the RSMD Workbook for Upper Face

  5. Complete the post-tests and obtain a passing score of 80%

  6. Complete the program evaluation

Joint Accreditation Statement:

Provided by UAMS after approval.

Credit Designation Statements:

Provided by UAMS after approval.

Disclosure Policy Statement

It is the policy of the University of Arkansas for Medical Sciences (UAMS), Office of Continuing Education (OCE) to ensure balance, independence, objectivity, and scientific rigor in all directly or jointly provided educational activities. All individuals who are in a position to control the content of the educational activity (course/activity directors, planning committee members, staff, teachers, or authors of CE) must disclose all relevant financial relationships they have with any commercial interest(s) as well as the nature of the relationship. The ACCME describes relevant financialrelationships as those in any amount occurring within the past 24 months that create a conflict of interest. Individuals who refuse to disclose will be disqualified from participation in the development, management, presentation, or evaluation of the CE activity.